Bone disease in β thalassemia patients: past, present and future perspectives
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 80, 66-79
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelinesIndian Journal of Endocrinology and Metabolism, 2013
- -Thalassemia Intermedia: A Clinical PerspectiveCold Spring Harbor Perspectives in Medicine, 2012
- A case of hypophosphatemic osteomalacia secondary to deferasirox therapyJournal of Bone and Mineral Research, 2011
- Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermediaHaematologica, 2011
- Paraspinal extramedullary hematopoiesis in patients with thalassemia intermediaEuropean Spine Journal, 2010
- Osteoporosis Syndrome in Thalassaemia Major: An OverviewJournal of Osteoporosis, 2010
- Excess iron inhibits osteoblast metabolismToxicology Letters, 2009
- Nutritional deficiencies in iron overloaded patients with hemoglobinopathiesAmerican Journal of Hematology, 2009
- Circulating osteoprotegerin and receptor activator of NF-κB ligand system in patients with β-thalassemia majorJournal of Bone and Mineral Metabolism, 2006
- Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosisJournal of Bone and Mineral Metabolism, 2003